Piramal Pharma Limited Announces Consolidated Results for Q4 and FY2023

MUMBAI, India, May 24, 2023 /PRNewswire/ — Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), today announced its consolidated results for the fourth quarter (Q4) and full year FY23 ended 31st March 2023. Consolidated Financial Highlights (In INR Crores) Particulars Quarterly Full Year Q4 FY23 Q4 FY22 YoYGrowth Q3 FY23 QoQGrowth FY23 FY22 YoYGrowth Revenue from … Read more

Biopharma-Führungskräfte treffen sich auf dem F&E- und Qualitätsgipfel von Veeva, um Innovationen für die Branche und die Patienten voranzutreiben

Bayer, Boehringer Ingelheim, GSK, LEO Pharma, Recordati, Syneos Health und weitere Unternehmen  teilen ihre Erkenntnisse zur Steigerung der Effizienz im gesamten Produktentwicklungszyklus BARCELONA, Spanien, 24. Mai 2023 /PRNewswire/ — Veeva Systems (NYSE: VEEV) gab heute bekannt, dass Führungskräfte von Bayer, Boehringer Ingelheim, GSK, LEO Pharma, Recordati und Syneos Health zu den Rednern des Veeva R&D and Quality … Read more

PRODUCTLIFE GROUP ERWIRBT CILATUS UND ERWEITERT DIE KOMPETENZ IN DER ENTWICKLUNG KOMPLEXER PRODUKTE

Nach den Übernahmen von DS InPharmatics (DSI) im Jahr 2021 und Zwiers Regulatory Consultancy im Jahr 2022 baut die ProductLife Group (PLG), ein globaler Anbieter von regulatorischen und Compliance-Dienstleistungen für die Life-Science-Branche, ihre Kapazitäten zur Unterstützung der Produktentwicklungsaktivitäten ihrer Kunden durch die Übernahme des in der Schweiz ansässigen Unternehmens Cilatus Biopharma Consulting und des in … Read more

Camurus announces FDA approval of Brixadi™ for the treatment of moderate to severe opioid use disorder

Brixadi is the first treatment for opioid use disorder in the US with both weekly and monthly dosing Three million people in the US diagnosed with opioid use disorder LUND, Sweden, May 24, 2023 /PRNewswire/ — Camurus (NASDAQ STO: CAMX) today announces that the US Food and Drug Administration (FDA) has approved Brixadi™ (buprenorphine) extended release … Read more

Increase in Pharmaceutical Production Drives Growth

DUBLIN, May 23, 2023 /PRNewswire/ — The “Flowmeter Global Market Report 2023” report has been added to  ResearchAndMarkets.com’s offering. This report provides strategists, marketers and senior management with the critical information they need to assess the market. The global flowmeter market grew from $8.13 billion in 2022 to $8.93 billion in 2023 at a compound … Read more

FDA Roundup: May 23, 2023

SILVER SPRING, Md., May 23, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Monday, the FDA and the Veterans Health Administration announced a new collaboration to jointly develop emergency preparedness and response tools and protocols intended to help increase medical product … Read more

Abbott Unveils Late-Breaking Data Showing the World’s First Dual-Chamber Leadless Pacemaker Study Met All Three Primary Endpoints

Abbott’s AVEIR™ DR i2i™ IDE study is the industry’s first prospective study on the safety and performance of the world’s first dual-chamber leadless pacemaker The study successfully met all three of its primary safety and performance endpoints Abbott’s investigational AVEIR DR leadless pacemakers have been submitted for evaluation by the U.S. FDA NEW ORLEANS, May … Read more

Increasing use of Telehealth Drives Growth

DUBLIN, May 19, 2023 /PRNewswire/ — The “Home Healthcare Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War” report has been added to  ResearchAndMarkets.com’s offering. The global home healthcare market is expected to grow at a CAGR of around 12.3% during 2023-2030. Companies Mentioned  Apple Home Healthcare. … Read more

EuroPCR 2023 | Résultats à 6 mois de l’étude SMART : contrôle satisfaisant de la pression artérielle obtenu avec une charge médicamenteuse réduite

PARIS, 20 mai 2023 /PRNewswire/ — Le 17 mai 2023, les résultats à six mois de l’étude SMART (Sympathetic Mapping/Ablation Renal nerves for Treatment of hypertension Trial ; NCT02761811) ont été publiés lors de la conférence Late Breaking Clinical Trial, faisant état de découvertes révolutionnaires dans le domaine de l’hypertension. Avec le professeur Huo Yong comme … Read more

Increasing Trend of Anti-Cellulite Massage Presents Opportunities

DUBLIN, May 19, 2023 /PRNewswire/ — The “Global Cellulite Treatment Market 2023-2030” report has been added to  ResearchAndMarkets.com’s offering. This research report predicts that the global cellulite treatment market will experience growth at a CAGR of 9.48% during the forecast period 2023-2030. The rise in beauty consciousness among consumers has led to a significant increase … Read more